Mindfulness-based cognitive therapy for patients with cancer

Mindfulness-based cognitive therapy for patients with cancer - MBCT for cancer patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016142

Enrollment

Registered

2015-01-07

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Mindfulness-based cognitive therapy group intervention Wait-list control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with stage 0 - III breast cancer 2.ECOG Performance Status of 0 to 2 3.Hospital Anxiety and Depression Scale >= 5 4.Clinical prognosis of one year or over 5.Willing to participate MBCT program for more than five sessions 6.Submission of written informed consent

Exclusion criteria

Exclusion criteria: 1.Severe physical or mental symptoms which hamper study participation 2.Past experience of MBCT or MBSR 3.Judgement of primary care provider as ineligible for the study

Design outcomes

Primary

Measure	Time frame
Depression and anxiety, measured by Hospital Anxiety and Depression Scale (HADS)	—

Secondary

Measure	Time frame
QoL: Functional Assessment of Cancer Therapy- General(FACT-G) Spiriuality: Functional Assessment of Cancer Therapy- Spiritual Well-Being(FACIT-Sp) State of mindfulness: Five Facet Mindfulness Questionnaire(FFMQ) Fear of cancer recurrence and progression: Concerns about Recurrence Scale-J(CARS-J) Fatigue: Brief Fatigue Inventory Health utility score: EuroQoL-5 (EQ-5D) Salivary amylase concentration	—

Measure

Time frame

QoL: Functional Assessment of Cancer Therapy- General(FACT-G) Spiriuality: Functional Assessment of Cancer Therapy- Spiritual Well-Being(FACIT-Sp) State of mindfulness: Five Facet Mindfulness Questionnaire(FFMQ) Fear of cancer recurrence and progression: Concerns about Recurrence Scale-J(CARS-J) Fatigue: Brief Fatigue Inventory Health utility score: EuroQoL-5 (EQ-5D) Salivary amylase concentration

—

Countries

Japan

Contacts

Public ContactDaisuke Fujisawa

Keio University School of Medicine

dfujisawa@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026